000 | 01817ngm a2200361 a 4500 | ||
---|---|---|---|
001 | HST5049 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 200304s2020 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a5049 _bHenry Stewart Talks |
035 | _a(UkLoHST)4056 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aKrassova, Snejana, _u(Bayer, Switzerland) _4spk |
|
245 | 1 | 0 |
_aHemophilia A _h[electronic resource] / _cSnejana Krassova. |
260 |
_aLondon : _bHenry Stewart Talks, _c2020. |
||
300 |
_a1 online resource (1 streaming video file (31 min.) : _bcolor, sound). |
||
490 | 1 |
_aPeriodic reports : advances in clinical interventions and research platforms, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Introduction to hemophilia A -- Diagnosis and severity of hemophilia -- Clinical manifestations and disease progression -- Current treatment: on-demand versus prophylactic replacement therapy -- HemACTIVE program identify how disease affects patients daily lives -- New therapeutic options present new possibilities -- FVIII: the standard of care in hemophilia A -- Approaches to extending FVIII half-life -- Adapting FVIII replacement therapy will meet a patient's individual needs. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aHemophilia. | |
650 | 2 | _aDisease Progression. | |
650 | 2 | _aFactor VIII. | |
650 | 2 |
_aHemophilia A _xdiagnosis. |
|
650 | 2 |
_aHemophilia A _xtherapy. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pPeriodic reports. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4056/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1048/ _3Series |
999 |
_c76102 _d76102 |